Oklahoma recalls

Some Omnipod DASH Pods have a manufacturing defect in the soft cannula (the tiny tube that delivers insulin) that can cause insulin to leak around the pod instead of into your body. This means you may receive less insulin than needed, which can lead to high blood sugar levels.

Some Omnipod 5 insulin pump pods have a manufacturing defect in the soft cannula (the small tube that delivers insulin) that can cause insulin to leak outside the pod instead of being delivered into the body. This under-delivery of insulin can lead to high blood sugar levels. In severe cases, prolonged high blood sugar can result in diabetic ketoacidosis or other serious complications.

The nebulizer cup on Hillrom VOLARA System patient circuits may not lock properly during setup, allowing air and medication to leak during therapy. This leakage can reduce oxygen delivery to the patient and prevent medication from being administered as prescribed.

The nebulizer cup on Hillrom VOLARA System patient circuits may not lock properly during setup, causing air and medication to leak during therapy. This leakage can reduce oxygen levels and prevent medications from being delivered as prescribed.

The nebulizer cup on Hillrom Volara P.Circuit 5Kit devices can leak air and medication if not properly locked during setup. This leakage may reduce oxygen delivery to the patient and prevent the prescribed medication from being delivered effectively.

The nebulizer cup on Hillrom VOLARA System breathing circuits may not lock properly after medication is added, causing air and medication to leak during therapy. This leakage can reduce oxygen delivery to the patient and prevent the prescribed medication from being effectively inhaled.

Medline's Ophthalmic Pack with Lidocaine (Model DYNJ57922A) contains lidocaine ampules manufactured by Huons Co., Ltd. that have quality issues identified during an FDA inspection of the manufacturing facility. About 180 kits were distributed nationwide.

Medline Industries is recalling three models of circumcision procedure kits because they contain lidocaine ampules with quality issues. The ampules were made by Huons Co., Ltd. and problems were found during an FDA manufacturing inspection. No injuries have been reported.

Medline's L&D Continuous Epidural Tray (Model PAIN1699A) contains Lidocaine Ampules that were recalled by the manufacturer, Huons Co., Ltd., due to quality problems found during an FDA inspection. About 432 kits with this component have been distributed nationwide.

Medline's Lumbar Puncture Choice Kit (Model DYNDH1215) contains Lidocaine Ampules manufactured by Huons Co., Ltd. that have quality issues identified during an FDA inspection of the manufacturer's facility. The affected kits were distributed nationwide.

Medline Industries is recalling two medical convenience kits that contain Lidocaine Ampules from Huons Co., Ltd. The Lidocaine was flagged for quality issues during an FDA inspection of the manufacturer's facility. About 250 kits were distributed nationwide.

Multiple Medline medical kits containing lidocaine ampules manufactured by Huons Co., Ltd. are being recalled due to quality issues found during an FDA inspection of Huons' manufacturing facility. The affected kits are used for various surgical and medical procedures including suturing, chest tube insertion, biopsies, and arterial line placement.

Medline Industries has recalled multiple medical procedure kits (central line, arterial line, dialysis, biopsy, and suturing kits) because they contain lidocaine ampules with quality issues. The lidocaine supplier, Huons Co., Ltd., issued a recall after the FDA inspected their manufacturing site and identified problems. No injuries have been reported.

Medline Convenience Kits (Model SUT13710) contain Lidocaine Ampules that were subject to a recall by the manufacturer Huons Co., Ltd. due to quality issues found during an FDA inspection of their manufacturing facility. About 176 kits were distributed nationwide.

Medline's Imaging Biopsy Tray (Model DYNDH1068) and Breast Biopsy Pack (Model PHS234706I) contain lidocaine ampules that were identified as defective during an FDA manufacturing inspection. The ampules were supplied by Huons Co., Ltd. and may not meet quality standards. Approximately 40 kits are affected nationwide.

Medline Convenience Kits containing Huons Lidocaine HCL Injection ampules are being recalled due to quality issues found during an FDA manufacturing inspection. The affected kits include two introducer models (6F and 9F) distributed nationwide. No injuries have been reported.

Medline Industries is recalling three models of medical convenience kits that contain Lidocaine Ampules manufactured by Huons Co., Ltd. The ampules were recalled due to quality issues found during an FDA inspection of the manufacturing facility. The affected kits are used in radiology, pain management, and endovenous procedures.

Medline is recalling 34 different models of central line insertion kits that contain lidocaine ampules manufactured by Huons Co., Ltd. The ampules were found to have quality issues during an FDA inspection of the manufacturer's facility. Approximately 967 kits are affected.

Medline's Convenience Kits (Model DYNJRA1590) contain Lidocaine Ampules that were recalled by the manufacturer, Huons Co., Ltd., due to quality issues found during an FDA manufacturing inspection. About 270 kits were distributed nationwide.

Medline distributed convenience kits containing lidocaine ampules manufactured by Huons Co., Ltd. The FDA identified quality issues with the lidocaine during a manufacturing inspection of Huons' facility. The affected kits are used for epidural anesthesia and pain management procedures.

Medline's arterial access and line insertion kits contain Lidocaine ampules from Huons Co., Ltd. that have quality defects. The defects were identified during an FDA inspection of the Lidocaine manufacturer's facility. The affected kits were distributed nationwide.

Certain coaxial breathing circuit sets used with Hamilton Medical ventilators (models C1, T1, and MR1) may have expiratory valve membranes that stick to the valve body. This defect is not always detectable before use and can trigger an "exhalation obstructed" alarm during ventilation, potentially leading to inadequate ventilation and oxygen desaturation in patients.

Nara Organics Whole Milk Organic Infant Formula in two sizes may be contaminated with Clostridium botulinum, a bacterium that can cause botulism. The contamination was identified in specific lot codes with use-by dates between March 2027 and February 2028. No illnesses have been reported.

MorningStar Farms Hot & Spicy Sausage Patties (8 oz. bags, UPC 028989100948) may contain plastic material. The affected products have "Best If Used By" dates of July 5, 6, or 7, 2027 and were distributed nationwide.

MorningStar Farms Buffalo Chik'n Nuggets (10.5 oz bags, UPC 028989101105) may contain plastic material. The affected products have a "Best If Used By" date of July 7 or 8, 2027. No injuries have been reported.

MOGO Pure Moringa Oleifera capsules may be contaminated with Salmonella Typhimurium. The contamination was discovered during testing. Affected bottles were sold online through Amazon, eBay, Etsy, and mogomiranga.com.

Cipla USA is recalling Cinacalcet Hydrochloride 90 mg tablets (lot 5PB0563, expiring 4/30/2027) because they contain elevated levels of N-nitroso-cinacalcet, a potentially harmful impurity that exceeds acceptable daily intake limits. This is a manufacturing quality issue.

Cipla USA is recalling certain batches of Cinacalcet Hydrochloride 60 mg tablets because they contain N-nitroso-cinacalcet, a chemical impurity, at levels above the FDA's acceptable daily intake. The affected lots were distributed nationwide. No injuries have been reported.

Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain elevated levels of N-nitroso-cinacalcet, a manufacturing impurity that exceeds FDA safety limits. The affected bottles were distributed nationwide.

Lannett Company distributed amphetamine extended-release capsules that contained only immediate-release pellets but were labeled as extended-release. This labeling error could result in incorrect dosing and medication timing for patients who depend on the extended-release formulation.